Leading cardiologists to address safety concerns surrounding drug-eluting stents

Top experts to provide perspective on late stent thrombosis at TCT 2006 press conference

WASHINGTON, DC, October 24, 2006 -- The safety of drug-eluting stents (DES) is a hotly discussed topic at the Transcatheter Cardiovascular Therapeutics Symposium (TCT 2006), and a panel of the world's top interventional cardiologists will answer questions regarding the concerns at a special press conference Wednesday. The experts will provide perspective on recent data regarding late stent thrombosis and address key questions including:

  • Are certain types of patients better candidates for DES than others?

  • Should DES be used off-label?

  • Why do data analyses differ?

  • Might risks vary with different stents?

  • Might additional studies be needed to better understand DES risks?

  • What should doctors tell patients about bare metal stents vs. drug-eluting stents?

WHEN: Wednesday, October 25, 2:00-2:30 p.m.

WHERE: TCT 2006 at the Washington Convention Center
Press Briefing Room 159A

CALL-IN #: Press can participate by phone by calling 877-425-3373 in the U.S. or 706-679-4937 internationally. The conference ID number is 9498441.

WHO: The press conference will be moderated by:

  • Martin B. Leon, M.D., Professor of Medicine at Columbia University College of Physicians and Surgeons and Associate Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center

  • Jeffrey W. Moses, M.D., Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center

The press conference panelists will be:

  • Stephen G. Ellis, M.D., Director, Sones Cardiac Cath Lab, The Cleveland Clinic Foundation

  • Barry F. Uretsky, M.D., Chief, Division of Cardiology, University of Texas Medical Branch

  • William W. O'Neill, M.D., Executive Dean for Clinical Affairs, Leonard M. Miller School of Medicine, University of Miami

  • Spencer B. King, III, M.D., M.A.C.C., Fuqua Chair of Interventional Cardiology, Fuqua Heart Center at Piedmont Hospital, Professor of Medicine Emeritus in Cardiology, Emory University School of Medicine.

###

Last reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
    Published on PsychCentral.com. All rights reserved.

 

 

Nothing in life is to be feared. It is only to be understood.
-- Marie Curie